


Researchers Find Link Between Cardiovascular Health, MSK Injuries

Advanced Ultrasound Paired With AI Diagnoses Thyroid Cancers

More Regular Mammography Screenings Improves Survival After Breast Cancer Diagnosis

COVID Variant, Severity of Illness Influence Cardiac Dysfunction

AI Predicts Breast Cancer Risk Better Than Standard Clinical Risk Model
GE HealthCare Launches Sonic DL for up to 12 Times Faster MR Imaging

Philips Adds Hyperpolarized Xenon Imaging to 3T MR With Polarean Agreement

AI Analyzes MRI Images to Help Predict Rheumatoid Arthritis

PET/CT Depicts Cardiovascular Risk in Patients with Psoriatic Arthritis Inflammation

Argon Adds New Device to Soft Tissue Biopsy Portfolio

Ezra Nets FDA Clearance for AI-Based MRI Solution

QuantalX Nets FDA Breakthrough Designation for Normal Pressure Hydrocephalus Device

AI Processing Tool for MRI Shows Changes in Brain Structure From Concussions

FDA Clears GE HealthCare’s Deep-Learning Solution for Enhanced PET/CT Image Quality

FUJIFILM Sonosite Releases All Touchscreen Point-of-Care Ultrasound

Evaluating AI for Academic and Private Healthcare Settings

LG Launches Its First Medical Monitor With IPS Black Technology

Clinical Trial Demonstrates Positive Effect Protecting DNA From Radiation Exposure

Deep-Learning Framework Developed for Super-Resolution Ultrasound

FDA Approves Radiohybrid PSMA PET Imaging Agent, POSLUMA

Dr. Richard Towbin Awarded the 2023 SPR Gold Medal

NCCN Recommends FES PET for ER+ Positive Recurrent or Metastatic Breast Cancer Patients

Shimadzu Adds Konica Minolta Glassless FPD to RF Systems

Pairing AI with Breast Density Algorithms Helps Predict Long-Term Cancer Risk

Photon-Counting CT Delivers Higher SNR, CNR Than Dual-Source CT in Infants

Siemens Healthineers and CommonSpirit Health to Acquire Block Imaging

DL-Based CAD Improves Breast Ultrasound Expertise

The Economics of AI Adoption

UCLA Health to Open Theranostics Center

Guerbet and Applied Radiology Launch Elucirem | The Reveal Image Challenge

First Patient Treated in RADIATE-VT Cardiac Radioablation Trial

MRI-Based Imaging Tool to Help Researchers Study the Brain During Swallowing

Brain MRI Analysis Software Nets FDA Clearance

Philips Introduces AI-Powered CT

Cyclotron for Alpha-Emitting Radioisotopes Launched by ACSI

Myosteatosis Increases Mortality Risk

Latest Version of ChatGPT Passes Radiology Board Exam
Reperfusion in COVID Vaccine-Naïve Patients Promotes Infarction Growth

Amino Acid PET Differentiates Recurrent Brain Metastases From Treatment-Related Changes
Showing articles tagged with PET

COVID Variant, Severity of Illness Influence Cardiac Dysfunction

PET/CT Depicts Cardiovascular Risk in Patients with Psoriatic Arthritis Inflammation

FDA Approves Radiohybrid PSMA PET Imaging Agent, POSLUMA

NCCN Recommends FES PET for ER+ Positive Recurrent or Metastatic Breast Cancer Patients

Amino Acid PET Differentiates Recurrent Brain Metastases From Treatment-Related Changes

Additional Results of Phase 3 SPOTLIGHT Trial of PET Imaging Trial Reported at AUA 2023

Active Surveillance Preferred by US Prostate Cancer Patients

Heart Inflammation After COVID Vaccine Found Only in Patients With Acute Myocarditis

Procedure Standard/Practice Guideline Published for Neuroendocrine Tumor PET Imaging

Phase III Study Reports Telix Kidney Cancer Imaging Agent Detects, Characterizes Renal Masses

Investigational PET Agent Detects Distant Metastases in Newly Diagnosed Prostate Cancer

Study Investigates Sensitivity of Radiopharmaceutical to Detect Acute Myocardial Inflammation

Mayo Clinic to Lead Study of New Radiotracer for Detecting Pancreatic Cancer

PSMA PET/MRI Accurately Predicts Prostate Cancer Recurrence Risk

Whole-Body PET Scans Highlight Complexity of Immunotherapy Response

Imaging May Improve Clinical Guidance in Immunotherapy
AI Adoption into Radiology Clinical Practice

Illuccix Now Available on High-Activity Gallium Generators

Phase III ZIRCON Study of PET Imaging Agent Meets Endpoints

First Patient Dosed in Phase IIb iPREDICT Trial for CD8 ImmunoPET

PET Radiotracer Detects Early Signs of Alzheimer’s Disease

First Patient Imaged in PSMA-Negative Prostate Cancer Trial

FDG-PET Predicts Neoadjuvant Therapy Response in Pre-Op Pancreatic Cancer Patients

Blue Earth Files for FDA Approval of Radiohybrid PSMA PET Imaging Agent

[18F]Flurpiridaz PET May Improve Coronary Artery Disease Detection

PET/MR Recommended for Diagnosing Chronic Osteomyelitis, if Available

If Available, PET/MR Recommended for Diagnosing Chronic Osteomyelitis

Reduced Myocardial Blood Flow Linked to COVID-19

First Total-Body PET Scans Completed with Illuccix For Prostate Cancer Imaging

Radialis PET Imager Receives FDA Clearance

SNMMI, ASNC Letter Leads to Aetna Coverage Reversal for Cardiac PET/CT

New Radiopharmaceutical Pair Detects, Treats Melanoma

Prostate Cancer Therapy Guidelines Need Updating

SNMMI 2022 Abstract of the Year: Radionuclide Treatment for Advanced-Stage Neuroendocrine Tumors

RefleXion, Telix Expand Prostate Cancer Treatment Partnership

Patient Enrollment Complete for Phase 3 18F-Fluciclovine PET Imaging of Recurrent Brain Mets

Clarity Receives FDA IND Approval for Phase II SAR-Bombesin Imaging Trial for Prostate Cancer

Full-Body PET Identifies Biomarkers of Joint Inflammation

New N-13 Ammonia Manufacturing Site Approved in South Florida

Additional Results From SPOTLIGHT Trial of Recurrent Prostate Cancer Announced at AUA 2022
Showing articles tagged with PET
© Anderson Publishing, Ltd. 2023 All rights reserved. Reproduction in whole or part without express written permission Is strictly prohibited.